Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Utah Medical Products Inc. (UTMD:NASDAQ), powered by AI.
Utah Medical Products Inc. is currently trading at $67.47. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Utah Medical Products Inc. on Alpha Lenz.
Utah Medical Products Inc.'s P/E ratio is 19.0.
“Utah Medical Products Inc. trades at a P/E of 19.0 (fair value) with solid ROE of 9.5%. Operating margin of 29.6% indicates strong profitability.”
Ask for details →Utah Medical Products Inc. is a company that specializes in manufacturing and distributing a diverse range of medical devices. Its core products cater primarily to critical care areas such as neonatal care, obstetrics, gynecology, and general surgery. The company's products include catheters, blood pressure monitoring kits, and specialized devices used in the labor and delivery rooms, which are crucial in providing optimal patient care during childbirth. Utah Medical Products serves a wide variety of healthcare facilities, including hospitals and outpatient clinics, underscoring its integral role in the medical supply chain. Established in 1978 and headquartered in Utah, USA, the company not only meets the needs of the domestic market but also extends its reach internationally. In the financial markets, Utah Medical Products Inc. is recognized for its consistent delivery of high-quality medical products that are essential in everyday healthcare operations, contributing significantly to the industry’s innovation and efficiency. This positions the company as an important player in the medical device sector, with a robust reputation built on reliability and performance.
“Utah Medical Products Inc. trades at a P/E of 19.0 (fair value) with solid ROE of 9.5%. Operating margin of 29.6% indicates strong profitability.”
Ask for details →Utah Medical Products Inc. (ticker: UTMD) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 155 employees. Market cap is $215M.
The current price is $67.47 with a P/E ratio of 19.05x and P/B of 1.8x.
ROE is 9.54% and operating margin is 29.60%. Annual revenue is $39M.